One stop for all your health tips

Choosing Between Levi’s 501, 505, 511, and 514? Start Here
Choosing Between Levi’s 501, 505, 511, and 514? Start Here
Winter Western: The Sendero Cloudcroft Hooded Puffer Jacket
Winter Western: The Sendero Cloudcroft Hooded Puffer Jacket
Three Day Rule: Why Matchmaking is the Future for Finding Real Lasting Love
Three Day Rule: Why Matchmaking is the Future for Finding Real Lasting Love
MENS HEALTH FITS. ALL RIGHTS RESERVED.

4

Jun , 2024
Novel combination treatment outperforms standard therapy in patients with EGFR NSCLC
Tag: Small Cell Lung Cancer

Novel combination treatment outperforms standard therapy in patients with EGFR NSCLC

The combination of the antibody amivantamab and lazertinib, a drug targeting EGFR, shows better clinical benefits compared to standard treatment in patients with advanced or metastatic non-small cell lung cancer with EGFR gene mutations who also present one of these poor prognostic markers: brain and/or liver metastases, p53 gene co-mutations, or the presence of circulating […]

26

May , 2024
AI-based body composition analysis predicts lung cancer treatment outcomes
Tag: Small Cell Lung Cancer

AI-based body composition analysis predicts lung cancer treatment outcomes

Tafadzwa Chaunzwa, MD, a researcher in the Artificial Intelligence in Medicine (AIM) Program at Mass General Brigham and a senior resident physician at the Harvard Radiation Oncology Program, is the lead author of a paper published in JAMA Oncology. Chaunzwa and senior author Hugo Aerts, PhD, director of the AIM Program, and associate professor at […]

4

Mar , 2024
Study highlights disparities in lung cancer treatment access across Europe
Tag: Small Cell Lung Cancer

Study highlights disparities in lung cancer treatment access across Europe

There are stark differences between European countries when it comes to both the reimbursement of, and access to, new treatments for patients with early-stage lung cancer. There are also differences in reimbursement times and indications between the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA). Researchers from Amsterdam UMC Cancer Center […]

16

Jan , 2024
Medicaid expansion associated with reduction in early mortality after lung cancer surgery
Tag: Small Cell Lung Cancer

Medicaid expansion associated with reduction in early mortality after lung cancer surgery

In a new, national, hospital-based study, researchers at the American Cancer Society (ACS) found that Medicaid expansion was associated with a statistically significant reduction in early mortality following surgical resection of stage I-III non-small cell lung cancer (NSCLC). The study results indicate that access to health insurance coverage via Medicaid expansion in the United States […]

18

Oct , 2023
New treatment options offer hope for patients with non-small cell lung cancer
Tag: Small Cell Lung Cancer

New treatment options offer hope for patients with non-small cell lung cancer

More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that target molecular alterations in tumor cells, with less need for chemotherapy, following results of multiple landmark clinical trials reported for the first time in late-breaking presentations at the ESMO Congress 2023. Better outcomes were achieved with combinations of experimental […]